Dr. Zhenpeng Qin's lab at the University of Texas Dallas focuses on innovative methods for delivering therapeutic molecules specifically to neurons and spinal cord tumors. By developing a peptide that can target neurons across various animal species and employing light-based techniques to modulate the blood-spinal cord barrier, the lab aims to enhance drug delivery for neurological diseases and cancers affecting the spinal cord. This work has significant implications for improving treatment options and understanding of central nervous system disorders.